← Leaderboards
Ranjit Ray
Saint Louis University
$8,996,397
Attributed
$9,848,584
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,848,584 · 8
By mechanism
R01$8,201,851 · 6
U54$1,486,733 · 1
R03$160,000 · 1
Top collaborators
- Ratna B Ray5 shared
Others in their field
Top investigators on “Hepatitis C Virus”
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Sharon A Nachman · Johns Hopkins University$91,575,784
- Peter B. Gilbert · Fred Hutchinson Cancer Center$77,122,577
- Robert Turner Schooley · University Of Colorado Denver$45,719,253
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$44,694,148
- Charles M. Rice · Rockefeller University$42,549,577
Research focus
Hepatitis C VirusHepatitis CInfectionLiver DiseasesViral ProteinsChronic Hepatitis CMediatingBaseCell Culture TechniquesViralGenotypeGlycoproteinsVirus DiseasesHepatocyteVirus EnvelopeMolecularGenesNeutralizing AntibodyImmune ResponseComplementary DnaVaccine DevelopmentVirus ProteinVaccinesGenerations
Grant awards (35)
SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION$327,240
R01 · FY2024 · DK · contact PI
SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION$340,875
R01 · FY2023 · DK · contact PI
SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION$340,875
R01 · FY2022 · DK · contact PI
Hepatitis C virus infection and mechanism of liver disease progression$340,875
R01 · FY2021 · DK · contact PI
SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION$340,875
R01 · FY2021 · DK · contact PI
Hepatitis C virus infection and mechanism of liver disease progression$340,875
R01 · FY2020 · DK · contact PI
SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION$340,875
R01 · FY2020 · DK · contact PI
Hepatitis C virus infection and mechanism of liver disease progression$340,875
R01 · FY2019 · DK · contact PI
Hepatitis C virus infection and mechanism of liver disease progression$340,875
R01 · FY2018 · DK · contact PI
Hepatitis C virus infection and mechanism of liver disease progression$340,875
R01 · FY2017 · DK · contact PI
Mechanisms of Liver Disease Progression by Hepatitis C Virus$303,424
R01 · FY2013 · DK · contact PI
Hepatitis C virus escape mechanisms from innate immunity$164,703
U54 · FY2013 · AI · contact PI
Mechanisms of Liver Disease Progression by Hepatitis C Virus$314,429
R01 · FY2012 · DK · contact PI
Hepatitis C virus escape mechanisms from innate immunity$160,090
U54 · FY2012 · AI · contact PI
Hepatitis C virus escape mechanisms from innate immunity$384,027
U54 · FY2011 · AI · contact PI
Mechanisms of Liver Disease Progression by Hepatitis C Virus$314,429
R01 · FY2011 · DK · contact PI
Hepatitis C virus escape mechanisms from innate immunity$398,529
U54 · FY2010 · AI · contact PI
Mechanisms of Liver Disease Progression by Hepatitis C Virus$350,460
R01 · FY2010 · DK · contact PI
Hepatitis C virus escape mechanisms from innate immunity$379,384
U54 · FY2009 · AI · contact PI
Mechanisms of Liver Disease Progression by Hepatitis C Virus$354,000
R01 · FY2009 · DK · contact PI
QUALITATIVE NATURE OF ANTIBODIES TO HCV GLYCOPROTEIN SUBUNIT VACCINE IN HUMANS$315,056
R01 · FY2009 · AI · contact PI
QUALITATIVE NATURE OF ANTIBODIES TO HCV GLYCOPROTEIN SUBUNIT VACCINE IN HUMANS$315,056
R01 · FY2008 · AI · contact PI
QUALITATIVE NATURE OF ANTIBODIES TO HCV GLYCOPROTEIN SUBUNIT VACCINE IN HUMANS$321,158
R01 · FY2007 · AI · contact PI
QUALITATIVE NATURE OF ANTIBODIES TO HCV GLYCOPROTEIN SUBUNIT VACCINE IN HUMANS$330,750
R01 · FY2006 · AI · contact PI
Functional Activities of HCV Core Protein$329,412
R01 · FY2005 · CA
Functional Activities of HCV Core Protein$244,833
R01 · FY2004 · CA
HCV ENVELOPE GLYCOPROTEINS AND VACCINE DEVELOPMENT$227,050
R01 · FY2003 · DK
Functional Activities of HCV Core Protein$21,105
R01 · FY2003 · CA
HCV ENVELOPE GLYCOPROTEINS AND VACCINE DEVELOPMENT$220,435
R01 · FY2002 · DK
Functional Activities of HCV Core Protein$198,450
R01 · FY2002 · CA
Functional Activities of HCV Core Protein$224,892
R01 · FY2001 · CA
HCV ENVELOPE GLYCOPROTEINS AND VACCINE DEVELOPMENT$214,016
R01 · FY2001 · DK
HCV CORE PROTEIN AND HEPATOCYTE GROWTH REGULATION$80,000
R03 · FY2001 · DK
HCV ENVELOPE GYCOPROTEINS AND VACCINE DEVELOPMENT$207,781
R01 · FY2000 · DK
HCV CORE PROTEIN AND HEPATOCYTE GROWTH REGULATION$80,000
R03 · FY2000 · DK